ICI-Based Urologic Cancer Therapies Tied to High Adverse Event Rates

Urologic cancer treatments based on immune checkpoint inhibitors are associated with a high incidence of treatment- and immune-related adverse events.

Related Keywords

China ,Changhai ,Liaoning ,Shanghai ,Jinling ,Jiangsu ,Nanjing ,Mingmin Li ,Naval Medical University ,Clinical School Of Medical College ,Jinling Hospital ,Clinical School ,Medical College ,Nanjing University ,Changhai Hospital ,